Low-dose IL2 therapy caused significantly increased expansion of natural killer (NK) cells which implicated potential augmentation of anti-infectious cellular immunity and possibly explained the lower incidence of treatment-associated severe infections in the patients [15]. This evidence concerns the gene IL2 and infection.